Member Info for Computer909

@SandyShore459, I completely understand the situation, the statement around "Vast agreeing to take on subsequent costs" is not in question, the debate is whether AP mining or VAST is the primary focus for AP. Decision's he makes on behalf of VAST look to sometimes only be for the benefit of AP mining and the detriment of VAST investors , We hope to see if and estimate worth of $100M for BP is anywhere realistic.

@Robsaunders, Thats true for his 81M VAST shares, AP Mining is a completely different legal entity that does not relate to the value of VAST, its 20% stake in BP has only increased by VAST taking it to a production mine, AP Mining hasn't contributed a penny to the cost. 20% of a mine reportedly worth $10M in 2018, now 20% of a mine which we hope to be worth multiples of that.

@Robsaunders, The 20% holding of AP Mining of the BP mine is no affected by any dilution of VAST shares.

@RottenRobbie, couldn't agree more, AP holdings in VAST of a little over £140K (most of which he bought at at 0.14 / 0.16) isn't his prime concern, AP Mining is, and it shows every time there is a bill to pay we get a placing diluting VAST more and not his share.

With AP at the helm, every bit of good news is very quickly followed bay a kick in the balls, hence the SP response i am afraid. Only news on refinancing will turn this around but i worry he will screw that up as well. If you look share dilution up in the dictionary it points you to VAST !

This is going no where with the idiot AP in charge, all trust has gone

We will always struggle to maintain any growth with the Idiot AP in charge, always hanging over us is his preference to make placings to pay the bills, he can't plan to save his life and just comes to us for a bale out. I am sure any positive news on sales will be accompanied with another reason to place some more shares, expansion down to next level, diamonds (what a joke), or more likely a new extension on his mansion.

And how exactly does that relate to a PI's investment seeing and increase in value?

Read the latest RNS with regards to selling P2F to Remote Monitoring Systems "RMS", it affects the SP because although BRH are increasing their holding of RMS in selling P2F, there is no direct link to the RMS share price and BRH share price, so although on paper an increase in the RMS share price makes BRH worth more, if that isn't reflected in BRH share price, then PI's see no benefit.

The problem being any good news for P2F, adds to RMS SP and detracts from BRH. Selling P2F is the worst thing for PI's invested in BRH, IMO

IMO, Money moving from BRH to RMS

Not sure we can compare the Novacyt contract for 25 weeks @£10M per week, with the scraps the UK government have given us at the moment

@MerchantBanker While I agree with you fundamentally, this is AIM, the only way we get a return on investment is an increase in the SP, without big contract news the SP we will just drift. The UK government contract was a good start and i am sure we will see a transformational change with the requirement for antibody test when any vaccine is released. If you look at the flip side of the UK contract awarded, it was less that two weeks full production run for ODX.

@Hypermarlin, I found the link embedded in this announcement

https://www.globenewswire.com/news-release/2020/08/12/2077212/0/en/QDX-HealthID-Signs-Distribution-Agreement-with-Innova-Medical-Group-Inc-Adding-Antigen-Molecular-and-Antibody-Tests-to-its-COVID-19-Test-Ecosystem.html

For test kit distribution opportunities, contact IMG’s global sales and distribution partner, COVIDSignals™ at enquiry@covidsignals.com, at (207) 271-9501, or by visiting www.covidsignals.com.

Would you spend $138M with someone with a global sales website that looks like that ?

The UK government are idiots, the sooner we get the UK-RTC/Mologic Antigen test available the better, but i'm sure they will make us jump through multiple approval hoops, these other tests aren't

The image on the innovemedgroup website actually shows the biotime test, so yes Chinese

http://www.biotime.cn/En_Pr_d_gci_80_id_69.html

Thanks Boris, for looking after UK business!

http://bidstats.uk/tenders/2020/W43/737214508

EMA head says three COVID vaccines could be approved early 2021 - ANSA https://lta.reuters.com/article/idUKKBN2711EF

And with it the demand for Antibody tests rockets ..

@Aberdeenman, I agree fully , with the government signing up to 390M vaccine doses across 6 possible suppliers, the stockpiling of the antibody test needed to support that is obviously necessary, and if you read between the lines has started already IMO.

@Mizman, If you find out you had it in March, would you treat the restrictions differently, thats the question the government are wrestling with, IMO